Lola Rahib, PhD Lead Scientist in Pancreatic Cancer at Cancer Commons
-
August 11, 2021
Researching More Second-Line Options for Pancreatic Cancer Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: A clinical trial is testing a promising treatment called eryaspase to see how well it performs as a second-line option for metastatic pancreatic cancer.
.
-
August 11, 2021
Anxiety Before Each Chemotherapy Treatment Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Pancreatic cancer patients share their experiences with pre-chemo anxiety and their personal strategies for overcoming it.
.
-
June 12, 2021
Improving Access to Genetic Testing and Counseling Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about eReach, a study investigating whether telehealth can provide improved access to genetic testing for people at risk for cancer.
.
-
June 12, 2021
Decoding the Differences between At-Home and Medical Genetic Testing Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about how the cost, access, accuracy, privacy and other aspects of at-home genetic testing compare to medical genetic testing with a specialist.
.
-
June 12, 2021
Tumor Biology Matters Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Results from the Know Your Tumor program shows overall survival benefit for patients with an actionable alteration and who received a matched therapy, compared to those with an actionable alteration and who did not receive a matched therapy.
.
-
June 12, 2021
NALIRIFOX Shows Promise in Early Studies Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: NALIRIFOX, a combination of liposomal irinotecan (Onivyde) with fluorouracil (5-FU), leucovorin, and oxaliplatin is shown to be safe as a first line treatment in locally advanced or metastatic pancreatic cancer.
.
-
June 12, 2021
Multi-Site Precision Promise Study Opens Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about Precision Promise, an adaptive multi-site clinical trial spearheaded by the Pancreatic Cancer Action Network.
.
-
June 12, 2021
New Trial to Find Biomarkers to Guide Treatment Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: A new clinical trial is using precision medicine to identify the best individualized standard-of-care options for pancreatic cancer patients.
.
-
June 12, 2021
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Modified FOLFIRINOX shows benefit as neoadjuvant therapy for borderline resectable pancreatic cancer.
.
-
June 12, 2021
Be Prepared: Putting Together an Emergency Preparedness Kit Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Be prepared for anything! 12 items to help you plan ahead for an emergency!
.